Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/782
Full metadata record
DC FieldValueLanguage
dc.date.accessioned2026-10-20T11:28:55Z-
dc.date.available2026-10-20T11:28:55Z-
dc.date.issued2021-01-01-
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/782-
dc.description120 pages: illustrations (chiefly colour); The document is a corporate code of practice, so Farmaindustria should be entered as the corporate author. If your copy is the September 2021 revised version, record that revision in the edition or notes field as appropriate.en_US
dc.description.abstractThe Code of Good Practices for the Pharmaceutical Industry establishes ethical standards governing the promotion of prescription medicines and interactions between pharmaceutical companies, healthcare professionals, healthcare organisations, and patient organisations. It promotes accurate and objective medicine information, professional conduct, transparency, integrity, and responsible collaboration. The 2021 edition addresses pharmaceutical promotion, scientific and educational activities, digital communication, disclosure of professional relationships, and mechanisms for monitoring compliance. The code aims to strengthen public trust, protect patients’ interests, and encourage ethical practices within the pharmaceutical industry.en_US
dc.language.isoenen_US
dc.publisherFarmaindustriaen_US
dc.subjectPharmaceutical industryen_US
dc.subjectPharmaceutical ethicsen_US
dc.subjectDrug promotionen_US
dc.subjectCode of practiceen_US
dc.subjectTransparencyen_US
dc.subjectSelf-regulationen_US
dc.titleCode of practice for the pharmaceutical industry 2021/en_US
dc.typeBooken_US
Appears in Collections:Pharmacy

Files in This Item:
File Description SizeFormat 
Code of Practice for the pharmceutical industry.pdf1.88 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.